Amiodaron in atrial fibrillation: post coronary artery bypass graft

doi:10.5847/wjem.j.1920-8642.2016.04.002

Abstract

Abstract:

BACKGROUND: Atrial fibrilation (AF) is the most common complication following heart surgeries; it often occurs in patients after coronary artery bypass graft (CABG). The purpose of this review is to categorize prophylaxes or treatment by administration of Amiodaron in patients with CABG.
DATA RESOURCES: We searched google scholar, pubmed, and Cochrane Library databases (the period 1970-2010) for articles on Amiodaron in CABG and cardiac surgery. A total of 1 561 articles were identified, and 30 articles met the criteria and were enrolled in this review.
RESULTS: Most studies supported Amiodarone for prophylaxi purpose in patients who were performed with CABG; few papers supported Amiodaron as a drug for treating CABG. The prophylaxis can decrease the incidence rate of AF in CABG, but if it uses as a treatment, the side effect of Amiodaron will decrease because all of the patients will not get Amiodarone. In the other hand use of Amiodarone as a treatment does not influence the length of hospital stay significantly but these kinds of study are so few.
CONCLUSION: No appropriate therapeutic method has been defined for AF. At present, the common way of treating AF following cardiac surgery is mainly based on prophylaxis in medical books and references.

Key words: Pulmonary aspiration, Lateral position, Semi-lateral position

Paria Habibollahi, Shahrzad Hashemi Jam, Samad Shams Vahdati, Hamidreza Morteza Baghi, Hassan Amiri. Amiodaron in atrial fibrillation: post coronary artery bypass graft[J]. World Journal of Emergency Medicine, 2016, 7(4): 250-254.

Figures/Tables 1

References 30

1	Redle ID, Khurana S, Marzan R, McCullough PA, Stewart JR, Westreer DC, et al. Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery. Am Heart J 1999; 138:144-150.
2	Brawnwald E. Heart disease. 7th Ed; 2005.
3	Katzung BG. Basic and clinical pharmacology. 8th Ed. Mc Graw-Hill; 2001.
4	Mason JW. Amiodaron. N Engle J Med 1987; 316:455-466.
5	Faniel R, Schoenfeld PH. Efficacy of i.v. amiodaron in converting rapid atrial fibrillation and flutter to sinus rhythm in intensive care patients. Eur Heart J 1983; 4:180-185.
6	Brugada P, Abdollah H, Heddle B, Wellens HJ. Results of a ventricular stimulation protocol using a maximum of 4 premature stimuli in patients without documented or suspected ventricular arrhythmias. Am J Cardiol 1983; 52:1214-1218. pmid: 6650409
7	Alboni P, Shanta N, Pirani R, Baggioni F, Scarfo S, Tomas AM. Effects of amiodaron on supraventricular tachycardia involving bypass tract. Am J Cardiol 1984; 53:93-98. pmid: 6691283
8	Rosenbavm MB, Chiale PA, Ryba D, Elizari MV. Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride. Am J Cardiol 1974; 34:215-223.
9	Andrivet P, Boubakri E, Dove PJ, Ngoc CV. A clinical study of amiodaron as a single oral dose in patients with recent - onset atrial tachyarrhythmia. Eur Heart J 1994; 15:1396-1402. pmid: 7821319
10	Escoubet B, Coumel P, Poirier JM, Maison-Blanche P, Jaillon P, Leclercq JF, et al. Suppression of arrhythmias within hours after a single dose of amiodaron and relation to plasma and myocardial concentrations. Am J Cardiol 1985; 55:696-702. pmid: 3976511
11	Fresco C, Proclemer A. Management of recent onset atrial fibrillation. Eur Heart J 1996; 17:41-47.
12	Falk RH. Proarrhythmia in patients treated for atrial fibrillation or flutter. Ann Intern Med 1992; 117:141-150.
13	Roden DM. Risk and benefits of antiarrhythmia therapy. N Engl J Med 1994; 331:785-791.
14	Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995; 333:77-82. doi: 10.1056/NEJM199507133330201 pmid: 7539890
15	Doral HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R. Randomized trial of low dose amiodarone in severe congestive heart failure. Lancet 1994; 344:493-498.
16	Evans SJL, Myers M, Zaher C, Simonson J, Nalos P, Vavghn C, et al. High dose oral amiodarone loading: electro physiologic effects and clinical tolerance. J Am Coll Cardiol 1992; 19:169-173.
17	Peukhurienen K, Niemela M, Ylitalo A, Linnalouto M, Lilja M, Juronen J. Effectiveness of amiodarone as a single oral dose for recent - onset atrial fibrillation. Am J Cardio 2000; 85:462.
18	Zebis LR, Christensen TD, Thomsen HF, MIkkelsen MM, Folkersen L, Sorensen HT, et al. Practical regimen for Amiodarone use in preventing postoperative atrial fibrillation. Ann Thorac Surg 2007; 83:1326-1331. pmid: 17383335
19	Zebis LR, Christensen TD, Thomsen HF, MIkkelsen MM, Folkersen L, Sorensen HT, et al. Amiodarone coast effectiveness in preventing atrial fibrillation after coronary artery bypass graft surgery. Ann Thorac Surg 2008; 85:28-33. pmid: 18154772
20	Budeus M, Hennersdorf M, Perings S, Rohlen Sh, Schnitzler S, Felix O, et al. Amiodarone prophylaxis for atrial fibrillation of high risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized study. Eur Heart J 2006; 27:1584-1591. pmid: 16760210
21	Vietter-Ramus G, Veglio F, Marchisio U, Burzio P, Latini R. Efficacy and safety of short term intravenous amiodarone in supra ventricular tachyarrhythmia. Int J cardial 1992; 35:77-85.
22	Vahdati SS, Samadikhah J, Hakim SH, Azarfarin R, Ansarin M. Comparison of the length of hospital stay between the patients with atrial fibrillation treated with amiodarone and patients with normal sinus rhythm after coronary artery bypass graft. J Cardiovasc Thorac Res 2012; 4:17-20. pmid: 24250975
23	Guarnieri T, Nolan S, Gottlieb SO, Dudek A, Lowry DR. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial. J Am Coll Cardiol 1999; 34:343-347. doi: 10.1016/s0735-1097(99)00212-0 pmid: 10440143
24	Daoud EG, Strickberger SA, Man KC, Goyal R, Deeb GM, Bolling SF, et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after open heart surgery. N Engle J Med 1997; 337:1785.
25	Butler J, Harriss DR, Sinclair M, Westaby S. Amiodarone prophylaxis for tachycardias after Coronary artery Surgery: a randomized, double blind, placebo Controlled trial. Br Heart J 1993; 70:56-60. pmid: 8038000
26	Hohnloser SH, Meinerz T, Dammbacher T, Steiert K, Johnchen E, Zehender M, et al. Electrocardiographic and ant arrhythmic effects of intravenous amiodarone: results of prospective, placebo Controlled study. Am Heart J 1991; 121(1 Pt 1):89-95.
27	Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusef S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: A meta-analysis. Circulation 2002; 106:75-80.
28	Levy T, Fotopoulos G, Walker S, Rex S, Octave M, Paul V, et al. Randomized controlled study investigating the effect of biatrial pacing in prevention of atrial fibrillation after coronary artery bypass grafting. Circulation 2000; 102:1382-1387.
29	Hogue CW, Hyder ML. Atrial fibrillation after cardiac operation: risks, mechanisms, and treatment. Ann Thorac Surg 2000; 69:300-306.
30	Calò L, Bianconi L, Colivicchi F, Lamberti F, Loricchio ML, de Ruvo E, et al. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 2005; 45:1723-1728. pmid: 15893193

Pre-operation factors	In-operation factors	Post-operation factors
Age over than 75 years	CABG along with valve improvement operation	ARDS
AF records	Pulmonary vein venting	Longer ventilation
Hypertension	Bicaval venous	Consumption of high doses of NSAIDs
Male	Cannulation	Atrial pace after surgery
Records of congestive heart failure	Cross-clamp longer time
Anatomical distribution of coronary artery disease
Sudden stop of β-blockers consumption
Renal insufficiency
COPD
Weak function of left ventricle
MI records
Diabetes mellitus (DM)

[1]	Ichiro Takenaka, Kazuyoshi Aoyama. Prevention of aspiration of gastric contents during attempt in tracheal intubation in the semi-lateral and lateral positions [J]. World Journal of Emergency Medicine, 2016, 7(4): 285-289.
[2]	Endale G. Gebremedhn, Kefale D. Gebeyehu, Hintsawit A. Ayana, Keder E. Oumer, Hulgize N. Ayalew. Techniques of rapid sequence induction and intubation at a university teaching hospital [J]. World Journal of Emergency Medicine, 2014, 5(2): 107-111.